ORKA Q3 2022 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$28,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-1.94

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$45M

Total Liabilities

$2M

Stockholders' Equity

$43M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$28,000	-$27,000	-3.7%
Operating Income	-$2M	-$5M	+62.6%
Net Income	-$2M	-$5M	+50.5%